AKH Inc., Advancing Knowledge in Healthcare and Psychiatric Annals
AKH Inc., Advancing Knowledge in Healthcare and Psychiatric Annals
Table of Contents
Generalized Anxiety Disorder in Children and Adolescents: An Update
Nazish Imran, MBBS, FRCPsych, MRCPsych; Imran Ijaz Haider, MBBS, FRCPsych, MRCPsych, DPM; and Muhammad Waqar Azeem, MD, DFAACAP, DFAPA
Pediatric Depression: The Latest in Diagnosis and Treatment
Salma Malik, MD, MS, DFAACAP, FAPA; and Muhammad Waqar Azeem, MD, DFAACAP, DFAPA
Pediatric Somatic Symptom Disorder: An Overview
Neha Sharma, DO; Mary Daley, MD; and Teresa Vente, DO, MPH
Obsessive-Compulsive Disorder in Children and Adolescents: An Overview
Ammar Albanna, MD, FRCPC, IFAPA; Khalid Bazaid, MD, FRCPC, IFAPA; and Muhammad Waqar Azeem, MD, DFAACAP, DFAPA
Sponsorship Statement: This CME activity is jointly sponsored by AKH Inc., Advancing Knowledge in Healthcare and Psychiatric Annals.
Support Statement: There is no commercial support for this activity.
1. Describe the prevalence, diagnosis, and management of generalized anxiety disorder.
2. Recognize pediatric depression assessment and treatment.
3. Describe the evaluation and management of pediatric patients who present with somatic symptom disorder symptoms.
4. Recognize assessment and treatment of pediatric obsessive-compulsive disorder.
Faculty names and affiliations: See authors above
Guest Editor: Muhammad Waqar Azeem, MD, DFAACAP, DFAPA
Reviewer names: Jan Fawcett, MD, Editor, Psychiatric Annals; Andrew A. Nierenberg, MD, CME Coordinator, Psychiatric Annals
Disclosure statement: In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears at the beginning of each CME-accredited article in this issue and also on this page.
Faculty members report the following financial relationships:
Jan Fawcett, MD, has no relevant financial relationships to disclose.
Andrew A. Nierenberg, MD, has disclosed the following relevant financial relationships: Appliance Computing Inc. (Mindsite); Astra Zeneca; Brain Cells, Inc.; Brandeis University; Bristol Myers Squibb; Clintara, Dianippon Sumitomo/Sepracor; Eli Lilly and Company; EpiQ, Forest; Johnson and Johnson; Labopharm; Merck; Methylation Science; Novartis; PamLabs; PGx Health; Shire; Schering-Plough; Sunovion; Takeda/Lundbeck Pharmaceuticals; Targacept; Teva: Consultant. APSARD; Belvoir Publishing; Boston Center for the Arts; University of Texas Southwestern Dallas; Hillside Hospital; American Drug Utilization Review; American Society for Clinical Psychopharmacology; Bayamon Region Psychiatric Society; Baystate Medical Center; Canadian Psychiatric Association; Columbia University; Douglas Hospital/McGill University; IMEDEX; International Society for Bipolar Disorders; Israel Society for Biological Psychiatry; John Hopkins University; MJ Consulting; Massachusetts Association of College Counselors; Medscape; MBL Publishing; Physicians Postgraduate Press; Ryan Licht Sang Foundation; Slack Publishing; SUNY Buffalo; University of Florida; University of Miami; University of Wisconsin; University of Pisa; SciMed: Honoraria / travel expenses. Appliance Computing, Inc.; Brain Cells, Inc.: Stock options. AHRQ; Cephalon; Forest; Mylan; NIMH; PamLabs; Pfizer Pharmaceuticals; Takeda; Elan; Shire: Grant / research support.
Authors report the following financial relationships: Nazish Imran has no relevant financial relationships to disclose. Imran Ijaz Haider has no relevant financial relationships to disclose. Muhammad Waqar Azeem has no relevant financial relationships to disclose. Salma Malik discloses research support from Forest Pharmaceuticals and Pzifer for clinical trials. Neha Sharma has no relevant financial relationships to disclose. Mary Daley has no relevant financial relationships to disclose. Teresa Vente has no relevant financial relationships to disclose. Ammar Albanna has no relevant financial relationships to disclose. Khalid Bazaid has no relevant financial relationships to disclose. Signed disclosures are on file at AKH Inc., Advancing Knowledge in Healthcare.
Accreditation statement(s): This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and SLACK Incorporated. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.
Credit designation: AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 3 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Release date: October 1, 2017.
Expiration Date: November 1, 2020.
How to participate: To participate in this CME activity, you must read the learning objectives, answer the pretest questions, read the articles, complete the CME posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, AKH Inc., Advancing Knowledge in Healthcare will issue an AMA PRA Category 1 Credit(s)™ certificate.
Target audience: This CME activity is primarily targeted to patient-caring psychiatrists, physicians specializing in psychiatry and others allied to the field. There are no specific background requirements for participants taking this activity. Learning objectives and author disclosures are found at the beginning of each CME article.
Unlabeled and investigational usage statement: The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage.
Copyright statement: Copyright © 2017 by SLACK Incorporated. All rights reserved. No part of this publication may be reproduced without prior written consent of the publisher.
page 1 of 8
Please click on Next tab to advance through activity.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2019 Healio All Rights Reserved.
Children and adolescents all too often experience psychiatric symptoms and disorders that interfere with their development. Left untreated, they and their families suffer profound consequences—you only get one chance to be a child or adolescent. Treated, they have better outcomes with a better chance to master their developmental challenges and become who they were meant to be.